1. Japanese male and female adults aged 20 to
2. Determined as healthy by the investigator (Subjects with preexisting chronic medical
conditions determined to be stable may be included),
3. Must be available for the 12 month duration of the study,
4. Subjects must agree to use an acceptable method of birth control for 3 months after
study vaccination (if the subject or the subject's partner are/is capable of having
children).
1. Any contraindication to vaccination or vaccine components, including previous
anaphylactic reaction to any vaccine or vaccine-related components,
2. Unstable or serious chronic medical condition that would increase the subject's risk
of participation,
3. Immune system suppression or treatment with medications that suppress the immune
system,
4. Receipt of blood products or immunoglobulins within the past 12 months,
5. Any infection proven or suspected to be caused by S.aureus within the past 6 months,
6. A staff member at this site nor a relative of those site staff members, nor a
sponsor's employee directly involved in the conduct of this research study,
7. Living in a nursing home, long-term care facility or other institution or requiring
any types of nursing care,
8. A pregnant or a breast feeding woman.